Addus HomeCare Corporation (ADUS)
USD 105.0
(1.04%)
USD 105.0
(1.04%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 62.51 Million USD | 35.83% |
| 2022 | 46.02 Million USD | 1.99% |
| 2021 | 45.12 Million USD | 36.2% |
| 2020 | 33.13 Million USD | 31.29% |
| 2019 | 25.23 Million USD | 44.19% |
| 2018 | 17.5 Million USD | 28.62% |
| 2017 | 13.6 Million USD | 13.17% |
| 2016 | 12.02 Million USD | 3.45% |
| 2015 | 11.62 Million USD | -5.06% |
| 2014 | 12.24 Million USD | -36.05% |
| 2013 | 19.14 Million USD | 150.75% |
| 2012 | 7.63 Million USD | 485.41% |
| 2011 | -1.98 Million USD | -132.86% |
| 2010 | 6.02 Million USD | 67.35% |
| 2009 | 3.6 Million USD | -10.46% |
| 2008 | 4.02 Million USD | 1942.13% |
| 2007 | 197 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 20.16 Million USD | 11.53% |
| 2024 Q1 | 15.83 Million USD | -19.14% |
| 2024 Q2 | 18.07 Million USD | 14.21% |
| 2023 Q3 | 15.41 Million USD | 3.76% |
| 2023 Q2 | 14.85 Million USD | 17.18% |
| 2023 Q4 | 19.57 Million USD | 27.04% |
| 2023 Q1 | 12.67 Million USD | -14.14% |
| 2023 FY | 62.51 Million USD | 35.83% |
| 2022 Q4 | 14.76 Million USD | 27.89% |
| 2022 Q2 | 11.25 Million USD | 32.82% |
| 2022 FY | 46.02 Million USD | 1.99% |
| 2022 Q1 | 8.47 Million USD | -35.14% |
| 2022 Q3 | 11.54 Million USD | 2.6% |
| 2021 Q2 | 11.59 Million USD | 30.39% |
| 2021 Q1 | 8.89 Million USD | 5.27% |
| 2021 FY | 45.12 Million USD | 36.2% |
| 2021 Q3 | 11.57 Million USD | -0.17% |
| 2021 Q4 | 13.05 Million USD | 12.79% |
| 2020 Q4 | 8.44 Million USD | -7.35% |
| 2020 FY | 33.13 Million USD | 31.29% |
| 2020 Q3 | 9.11 Million USD | 32.03% |
| 2020 Q1 | 8.65 Million USD | -13.33% |
| 2020 Q2 | 6.9 Million USD | -20.22% |
| 2019 Q4 | 9.99 Million USD | 105.26% |
| 2019 Q2 | 5.51 Million USD | 13.49% |
| 2019 FY | 25.23 Million USD | 44.19% |
| 2019 Q1 | 4.86 Million USD | 1.25% |
| 2019 Q3 | 4.86 Million USD | -11.8% |
| 2018 Q1 | 4.85 Million USD | 49.89% |
| 2018 Q4 | 4.8 Million USD | 35.42% |
| 2018 FY | 17.5 Million USD | 28.62% |
| 2018 Q3 | 3.54 Million USD | -17.48% |
| 2018 Q2 | 4.29 Million USD | -11.55% |
| 2017 Q1 | 4.25 Million USD | -43.72% |
| 2017 Q4 | 3.24 Million USD | -4.9% |
| 2017 Q3 | 3.4 Million USD | 26.22% |
| 2017 FY | 13.6 Million USD | 13.17% |
| 2017 Q2 | 2.7 Million USD | -36.6% |
| 2016 FY | 12.02 Million USD | 3.45% |
| 2016 Q3 | 1.69 Million USD | -34.65% |
| 2016 Q2 | 2.6 Million USD | 1556.05% |
| 2016 Q1 | 157 Thousand USD | -95.27% |
| 2016 Q4 | 7.56 Million USD | 345.44% |
| 2015 Q3 | 2.88 Million USD | -11.25% |
| 2015 FY | 11.62 Million USD | -5.06% |
| 2015 Q4 | 3.32 Million USD | 15.03% |
| 2015 Q2 | 3.25 Million USD | 50.46% |
| 2015 Q1 | 2.16 Million USD | -44.89% |
| 2014 Q1 | 2.35 Million USD | 165.99% |
| 2014 Q2 | 4.46 Million USD | 89.76% |
| 2014 Q3 | 3.23 Million USD | -27.54% |
| 2014 Q4 | 3.92 Million USD | 21.19% |
| 2014 FY | 12.24 Million USD | -36.05% |
| 2013 Q2 | 2.43 Million USD | -81.66% |
| 2013 Q3 | 2.56 Million USD | 5.55% |
| 2013 Q4 | 885 Thousand USD | -65.52% |
| 2013 FY | 19.14 Million USD | 150.75% |
| 2013 Q1 | 13.26 Million USD | 254.1% |
| 2012 Q2 | 1.46 Million USD | 132.75% |
| 2012 FY | 7.63 Million USD | 485.41% |
| 2012 Q4 | 3.74 Million USD | 108.4% |
| 2012 Q1 | 629 Thousand USD | -87.12% |
| 2012 Q3 | 1.79 Million USD | 22.75% |
| 2011 FY | -1.98 Million USD | -132.86% |
| 2011 Q1 | 853 Thousand USD | -44.5% |
| 2011 Q2 | 1.33 Million USD | 56.27% |
| 2011 Q3 | -9.04 Million USD | -778.84% |
| 2011 Q4 | 4.88 Million USD | 153.95% |
| 2010 Q2 | 1.65 Million USD | 21.8% |
| 2010 Q1 | 1.35 Million USD | 176.12% |
| 2010 Q4 | 1.53 Million USD | 3.92% |
| 2010 Q3 | 1.47 Million USD | -10.58% |
| 2010 FY | 6.02 Million USD | 67.35% |
| 2009 Q2 | 1.93 Million USD | 41.47% |
| 2009 Q3 | 2.09 Million USD | 8.23% |
| 2009 FY | 3.6 Million USD | -10.46% |
| 2009 Q4 | -1.78 Million USD | -185.36% |
| 2009 Q1 | 1.36 Million USD | 24.89% |
| 2008 Q4 | 1.09 Million USD | -16.63% |
| 2008 FY | 4.02 Million USD | 1942.13% |
| 2008 Q3 | 1.31 Million USD | 0.0% |
| 2007 FY | 197 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 388.531% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | 1495.758% |
| Amedisys, Inc. | -9.74 Million USD | 741.387% |
| Astrana Health, Inc. | 60.71 Million USD | -2.963% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 146.472% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 3.31 Million USD | -1785.283% |
| Cryo-Cell International, Inc. | -9.52 Million USD | 756.566% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 13.927% |
| COMPASS Pathways plc | -118.46 Million USD | 152.772% |
| DocGo Inc. | 6.85 Million USD | -811.517% |
| The Ensign Group, Inc. | 209.39 Million USD | 70.145% |
| Healthcare Services Group, Inc. | 38.38 Million USD | -62.861% |
| InnovAge Holding Corp. | -21.33 Million USD | 392.98% |
| The Joint Corp. | -9.75 Million USD | 741.045% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 133.563% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 500.672% |
| ModivCare Inc. | -204.46 Million USD | 130.576% |
| NewGenIvf Group Limited | 130.19 Thousand USD | -47917.943% |
| Option Care Health, Inc. | 267.09 Million USD | 76.594% |
| P3 Health Partners Inc. | -57.77 Million USD | 208.21% |
| P3 Health Partners Inc. | -57.77 Million USD | 208.21% |
| The Pennant Group, Inc. | 13.37 Million USD | -367.27% |
| Surgery Partners, Inc. | -11.9 Million USD | 625.345% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | 2227.594% |
| Talkspace, Inc. | -19.18 Million USD | 425.91% |
| Talkspace, Inc. | -19.18 Million USD | 425.91% |
| The Oncology Institute, Inc. | -83.06 Million USD | 175.259% |
| The Oncology Institute, Inc. | -83.06 Million USD | 175.259% |